Use of the term ‘cannabis’ instead of ‘marijuana’ does not influence the public’s perception of the plant or their attitudes, according to data published in the journal PLOS One. Investigators concluded: “We find no support for the notion that changing the name of the drug from ‘marijuana’ to ‘cannabis’ affects public opinion on the drug or the policies governing it.”
A super-majority of Americans, including majorities of Democrats, Republicans, and Independents support making marijuana use legal in the United States, according to nationwide polling data compiled by Gallup.
The total number of persons arrested in the United States for violating marijuana laws rose for the third consecutive year, according to data released by the US Federal Bureau of Investigation.
Majority Leader Hoyer on Friday announced that members of the House are anticipated to hold a floor vote next week on The SAFE Banking Act (HR1595), which explicitly permits banks and other financial institutions to work directly with state-legal marijuana businesses.
Commercially marketed CBD-infused products are not subject to explicit federal regulations. As a result, third-party lab testing has frequently revealed inconsistencies between the percentage of CBD advertised and the amount actually contained in some of these products.
Last week, NORML leaders and activists from across North America headed to our nation’s capital for the annual NORML Conference and Congressional Lobby Day.
The Act states, “A public employer may not refuse to hire, terminate from employment, penalize, fail to promote, or otherwise take adverse employment action against an individual based upon the individual’s status as a qualifying patient.”
“Our current model of federal prohibition represents the utter lack of control over any aspect of marijuana or the marijuana market. The Surgeon General’s time would be better spent advocating for a legally and tightly regulated cannabis market – one in which we educate Americans about the potential harms and benefits of cannabis through evidence-based public education campaigns – rather than through fear-mongering.”
“For the past three years, the DEA has failed to take any steps to follow through on its promise to facilitate clinical cannabis research, and today’s announcement makes it clear that this foot-dragging will continue,” NORML Executive Director Erik Altieri said.
California health officials have identified a link between the use of unregulated vapor cartridges and patients seeking hospitalization for respiratory distress. In each of the cases, patients presented symptoms of Acute Respiratory Distress Syndrome and possessed a history of consuming either THC or CBD extracts via the use of unlicensed vapor cartridges.